This statistic shows the chronic hepatitis B therapeutics sales in 2014 and 2024, by major market. Sales for chronic hepatitis B therapeutics in the U.S. market were some 773 million U.S. dollars in 2014.
Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Pharmaceutical industry in Denmark
Position within Europe
3
Overview
5
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Premium Statistic Pharmaceutical revenue in pharmacies in Denmark by group 2022
- Basic Statistic Distribution pharmacy revenues in Denmark by product type 2022
- Basic Statistic Revenue of most dispensed drugs at pharmacies in Denmark 2022
- Premium Statistic Share of expenditure on pharmaceuticals in Denmark by type 2022
Key players
8
- Basic Statistic Leading pharmaceutical companies in Denmark 2023, by revenue
- Basic Statistic Employment at select top pharmaceutical companies in Denmark 2023
- Basic Statistic Net sales of Novo Nordisk 2009-2023
- Basic Statistic Net profit of Novo Nordisk 2009-2023
- Basic Statistic Revenue of LEO Pharma 2009-2023
- Basic Statistic Net profit/loss of LEO Pharma 2009-2023
- Basic Statistic Revenue of Lundbeck 2009-2023
- Basic Statistic Profit and loss of Lundbeck 2009-2023
Export, sales, purchase
5
- Basic Statistic Export value of medicinal and pharmaceutical products in Denmark 2010-2023
- Basic Statistic Domestic sales from the manufacture of basic pharmaceuticals in Denmark 2017-2023
- Basic Statistic Sales value of manufacture of basic pharmaceutical products in Denmark 2017-2023
- Basic Statistic Domestic purchase value of manufacture of basic pharmaceuticals in Denmark 2017-2023
- Basic Statistic Purchase value of manufacture of pharmaceutical products in Denmark 2017-2023
Patents and clinical trials
3
Further related statistics
10
- Medicaid long-term care services expenditures by type of service 1990-21
- Cost savings through urgent care vs emergency department 2012
- Net earnings of UnitedHealth Group 2007-2023
- Doctor visits in Germany - number per capita 1991-2021
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Leading causes of death among Black U.S. residents in 2020 and 2021
- Location of death among hospice patients in the U.S. 2018
- Key figures on established biotech centers worldwide 2012-2016
- Presence of mental ill health in England 2014, by gender
- Size of U.S. hospices by number of admissions 2012-2014
Further Content: You might find this interesting as well
Statistics
- Medicaid long-term care services expenditures by type of service 1990-21
- Cost savings through urgent care vs emergency department 2012
- Net earnings of UnitedHealth Group 2007-2023
- Doctor visits in Germany - number per capita 1991-2021
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Leading causes of death among Black U.S. residents in 2020 and 2021
- Location of death among hospice patients in the U.S. 2018
- Key figures on established biotech centers worldwide 2012-2016
- Presence of mental ill health in England 2014, by gender
- Size of U.S. hospices by number of admissions 2012-2014
GlobalData. (January 1, 2016). Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars) [Graph]. In Statista. Retrieved June 16, 2024, from https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/
GlobalData. "Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars)." Chart. January 1, 2016. Statista. Accessed June 16, 2024. https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/
GlobalData. (2016). Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars). Statista. Statista Inc.. Accessed: June 16, 2024. https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/
GlobalData. "Chronic Hepatitis B Therapeutics Sales in Selected Major Markets in 2014 and 2024 (in Million U.S. Dollars)." Statista, Statista Inc., 1 Jan 2016, https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/
GlobalData, Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars) Statista, https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/ (last visited June 16, 2024)
Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars) [Graph], GlobalData, January 1, 2016. [Online]. Available: https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/